SCHEMBL149453

SCHEMBL149453

CC(C)CCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCC(C)C

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.61
MAPT P10636 1/20 0.47
DNM1 Q05193 1/20 0.46
KDM4C Q9H3R0 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4A O75164 1/20 0.43
PHF8 Q9UPP1 1/20 0.43
KDM2A Q9Y2K7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 3/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PAM P19021 2/20 0.41
KDM4E B2RXH2 1/20 0.41
DUSP3 P51452 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889959 1.00 DGKA (0.61) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL1278461 1.00 DGKA (0.61) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL1011923 0.98 DGKA (0.57) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL2396997 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL50203 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL8961837 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL17812626 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL494789 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL494994 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1
SCHEMBL33694 0.94 DGKA (0.53) DGKAMAPTDNM1KDM4CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 781 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646706-B1 CHAIN LUBRICANTS ECOLAB INC (US) 2016-02-03 EP claimed
WO-2013170419-A1 EMULSIFIER COMPOSITION AND THE USE THEREOF Evonik Degussa (China) Co., Ltd. (CN) 2013-11-21 WO claimed
US-20260047989-A1 Compositions and Methods for Treating Skin Discoloration RACQUEL FRISELLA LLC (US) 2026-02-19 US disclosed
US-20260047990-A1 Compositions and Methods for Treating Skin Discoloration RACQUEL FRISELLA LLC (US) 2026-02-19 US disclosed
EP-4683610-A1 CATECHOL DERIVATIVES FOR TREATMENT OF SIGNS OF HAIR AGING AND/OR SCALP AGING Henkel AG & Co. KGaA (DE) 2026-01-28 EP disclosed
EP-3969013-B1 SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS TOPIX PHARMACEUTICALS INC (US) 2026-01-07 EP disclosed
US-20250302705-A1 TOPICAL VITAMIN C COMPOSITION TOPIX PHARMACEUTICALS INC (US) 2025-10-02 US disclosed
US-12350351-B2 Topical vitamin c composition TOPIX PHARMACEUTICALS, INC. (US) 2025-07-08 US disclosed
WO-2025106797-A1 TOPICAL MICROBIOME COMPOSITION TOPIX PHARMACEUTICALS, INC. (US) 2025-05-22 WO disclosed
EP-4543455-A2 METHODS OF TREATING NEUROLOGICAL VENTILATORY INSUFFICIENCY Enalare Therapeutics Inc. (US) 2025-04-30 EP disclosed
CN-119855583-A Composition for cosmetic treatment of keratin fibres 碧昂赛恩斯公司 2025-04-18 CN disclosed
WO-1995010259-A1 FREE FLOWING EMULSION CONCENTRATE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1995-04-20 WO disclosed
EP-0521981-B1 PROCESS FOR MANUFACTURING OIL-IN-WATER CREAMS HENKEL KGAA (DE) 1994-12-28 EP disclosed
EP-0600959-A1 EMULSIONS OF POLAR OILS IN WATER Henkel Kommanditgesellschaft auf Aktien (DE) 1994-06-15 EP disclosed
WO-1993005129-A1 EMULSIONS OF POLAR OILS IN WATER HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1993-03-18 WO disclosed
EP-0345586-B1 PROCESS FOR PREPARING STABLE LOW-VISCOSITY OIL-IN-WATER EMULSIONS OF POLAR OIL COMPONENTS Henkel Kommanditgesellschaft auf Aktien (DE) 1992-07-01 EP disclosed
WO-1992001507-A2 FLUID LONG-SHELF-LIFE DISPERSIONS OF PARTIAL FATTY ACID GLYCERIDES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1992-02-06 WO disclosed
EP-0419505-A1 PROCESS FOR PREPARING A STABLE, LOW-VISCOSITY OIL-IN-WATER EMULSION OF POLAR OIL COMPONENTS Henkel Kommanditgesellschaft auf Aktien (DE) 1991-04-03 EP disclosed
WO-1989011907-A1 PROCESS FOR PREPARING A STABLE, LOW-VISCOSITY OIL-IN-WATER EMULSION OF POLAR OIL COMPONENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1989-12-14 WO disclosed
EP-0345586-A1 Process for preparing stable low-viscosity oil-in-water emulsions of polar oil components Henkel Kommanditgesellschaft auf Aktien (DE) 1989-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260047990-A1 Compositions and Methods for Treating Skin Discoloration TYR, TH, DYRK1A DGKA 1099/4885MAPT 2079/4885DNM1 4078/4885
US-20260047989-A1 Compositions and Methods for Treating Skin Discoloration ALAD, ADSL, CUTA DGKA 749/4885MAPT 3864/4885DNM1 4242/4885
US-12350351-B2 Topical vitamin c composition PROC, TTPA, SOD3 DGKA 539/4885MAPT 372/4885DNM1 1653/4885
US-20250302705-A1 TOPICAL VITAMIN C COMPOSITION PROC, TTPA, SOD3 DGKA 539/4885MAPT 372/4885DNM1 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.